1. Electronic Health Record Transition and Impact on Screening Test Follow-Up
- Author
-
Tom Sequist, Griffith Bell, Sonali Desai, Karthik Sivashanker, Ramin Khorasani, Bridget A. Neville, Ronilda Lacson, and Stuart R. Lipsitz
- Subjects
Male ,medicine.medical_specialty ,Prostate biopsy ,Screening test ,Leadership and Management ,03 medical and health sciences ,0302 clinical medicine ,Abnormal PAP Smear ,Electronic health record ,Internal medicine ,medicine ,Electronic Health Records ,Humans ,030212 general & internal medicine ,Medical diagnosis ,Retrospective Studies ,Vaginal Smears ,Colposcopy ,Pap smears ,medicine.diagnostic_test ,business.industry ,030503 health policy & services ,Retrospective cohort study ,Female ,0305 other medical science ,business ,Follow-Up Studies ,Papanicolaou Test - Abstract
Introduction Nonurgent clinically significant test results (CSTRs) are a common cause of missed and delayed diagnoses. However, little is known about the impact of electronic health record (EHR) transitions on CSTR follow-up. This study examines follow-up rates for three CSTRs (incidental pulmonary nodules [IPNs]), prostate-specific antigen [PSA], and Pap smears) before and after EHR transition. Methods This is a retrospective cohort study at an urban tertiary medical center using an interrupted time series (ITS) design to assess monthly changes in CSTR follow-up—defined as completion of computed tomography chest imaging 5 to 13 months after first mention of an IPN in a radiology report; completion of a follow-up PSA test, urology visit, or prostate biopsy within 6 months of the first reported PSA > 4; or completion of a colposcopy or gynecology visit within 6 months of a first reported abnormal Pap smear. Patients were included with first-onset abnormal CSTRs for IPN, PSAs > 4, or abnormal Pap smears occurring in the 24 months before and after the EHR transition. Results There were no significant differences in follow-up in the IPN or the Pap smear ITS models. In the PSA ITS model, follow-up was significantly decreasing (p = 0.0133) in the preintervention period, and there was a significant change in trend from intervention to postintervention (p = 0.0279). Conclusion EHR transition reversed a decreasing trend over time for PSA test follow-up, while IPN and Pap smear follow-up trends did not change significantly. Effects of EHR transition may differ by test studied.
- Published
- 2021
- Full Text
- View/download PDF